Return to study ST001236 main page
MB Sample ID: SA088586
Local Sample ID: | CA209009-11-79_week 4 |
Subject ID: | SU001304 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR001319 |
Treatment Summary: | In CA209-009, NCT01358721, Nivolumab was administered intravenously every 3 weeks at 0.3, 2, or 10 mg/kg to previously treated patients and 10 mg/kg to treatment-naïve patients with metastatic renal cell carcinoma (mRCC). |
Treatment Protocol ID: | NCT01358721 |